VERACYTE, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.94M, a 17.73% increase year-over-year.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $0.00.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $1.41M, a 18.07% increase year-over-year.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $3.05M, a 5.75% increase from fiscal 2024.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $2.89M, a 8.47% decline from fiscal 2023.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $3.15M, a 15.88% decline from fiscal 2022.
- VERACYTE, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $3.75M, a 59.29% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $3.34M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $1.94M 10-Q · filed 2026-05-06 | $3.34M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.05M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.41M 10-Q · filed 2025-11-05 | $3.05M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $2.84M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $1.65M 10-Q · filed 2026-05-06 | $2.84M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.89M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.19M 10-Q · filed 2025-11-05 | $2.89M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.70M 10-Q · filed 2025-05-08 | $2.88M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.15M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.18M 10-Q · filed 2024-11-07 | $3.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $3.61M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.97M 10-Q · filed 2024-05-08 | $3.61M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.75M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.63M 10-Q · filed 2023-11-08 | $3.75M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $2.12M 10-Q · filed 2023-05-05 | $3.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.35M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.20M 10-Q · filed 2022-11-03 | $2.35M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.09M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $1.16M 10-Q · filed 2022-05-04 | $2.09M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.04M 10-K · filed 2023-03-01 |
| 2020-09-30 | $935.00K 10-Q · filed 2021-11-09 | $2.04M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $1.88M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.10M 10-Q · filed 2021-05-10 | $1.88M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.27M 10-K · filed 2022-02-28 |
| 2019-09-30 | $774.00K 10-Q · filed 2020-11-02 | $1.26M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $884.00K derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $491.00K 10-Q · filed 2020-05-06 | $884.00K derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $790.00K 10-K · filed 2021-02-22 |
| 2018-09-30 | $393.00K 10-Q · filed 2019-10-22 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-07-30 | |
| 2018-03-31 | $397.00K 10-Q · filed 2019-04-30 | |
| 2017-12-31 | $656.00K 10-K · filed 2020-02-25 | |
| 2016-12-31 | $678.00K 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |